In this month’s edition we have a EuroIntervention State-of-the-Art on the management of cardiogenic shock outlining the latest treatments and emerging data. In coronary interventions: the COOL AMI EU trial evaluating the safety and efficacy of rapid systemic intravascular hypothermia as an adjunctive therapy to primary percutaneous interventions in patients with ST-elevation myocardial infarction; the RE-DUAL PCI trial, where the safety and efficacy of dabigatran dual therapy plus a P2Y12 inhibitor was evaluated against warfarin triple therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention for ST-elevation myocardial infarction; the ISAR-CALC trial, on the efficacy and safety of balloon-based techniques in preparing severely calcified coronary lesions for stenting; the impact of neoatherosclerosis on prognosis after percutaneous coronary interventions for in-stent restenosis; the four-year outcomes of the EROSION study which followed the effectiveness of an antithrombotic therapy without stenting in treating acute coronary syndromes caused by erosion; a mini focus on spontaneous coronary artery dissection (SCAD) including the relationship between SCAD and fibromuscular dysplasia and genetic links to SCAD; the clinical impact of SCAD angiographic classifications, and more...
Coronary interventions
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial
Noc M, Laanmets P, Neskovic A, Petrović M, Stanetic B, Aradi D, Kiss R, Ungi I, Merkely B, Hudec M, Blasko P, Horvath I, Davies J, Vukcevic V, Holzer M, Metzler B, Witkowski A, Erglis A, Fister M, Nagy G, Bulum J, Édes I, Peruga J, Średniawa B, Erlinge D, Keeble TR
10.4244/EIJ-D-21-00348
free
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial
Zeymer U, Leiva O, Hohnloser S, Steg G, Oldgren J, Nickenig G, Gabor Kiss R, Ongen Z, Navarro Estrada J, Oude Ophuis T, Lip G, Nordaby M, Miede C, ten Berg JM, Bhatt D, Cannon C
10.4244/EIJ-D-20-00799
free
Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial
Rheude T, Rai H, Richardt G, Allali A, Abdel-Wahab M, Sulimov D, Mashayekhi K, Ayoub M, Cuculi F, Bossard M, Kufner S, Xhepa E, Kastrati A, Fusaro M, Joner M, Byrne RA, Cassese S
10.4244/EIJ-D-20-01000
free
Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis
Nakamura D, Dohi T, Ishihara T, Kikuchi A, Mori N, Yokoi K, Shiraki T, Mizote I, Mano T, Higuchi Y, Yamada T, Nishino M, Sakata Y
10.4244/EIJ-D-20-00539
free
Predictors of non-stenting strategy for acute coronary syndrome caused by plaque erosion: four-year outcomes of the EROSION study
He L, Qin Y, Xu Y, Hu S, Wang Y, Zeng M, Feng X, Liu Q, Syed I, Demuyakor A, Zhao C, Chen X, Li Z, Meng W, Xu M, Liu H, Ma L, Dai J, Xing L, Yu H, Hou J, Jia H, Mintz GS, Yu B
10.4244/EIJ-D-20-00299
free
Coronary interventions - Mini focus on spontaneous coronary dissections
National French registry of spontaneous coronary artery dissections: prevalence of fibromuscular dysplasia and genetic analyses
Combaret N, Gerbaud E, Derimay F, Souteyrand G, Cassagnes L, Bouajila S, Berrandou T, Rangé G, Meneveau N, Harbaoui B, Lattuca B, Bouatia-Naji N, Motreff P
10.4244/EIJ-D-20-01046
free
Clinical outcomes by angiographic type of spontaneous coronary artery dissection
Mori R, Macaya F, Giacobbe F, Salinas P, Pavani M, Boi A, Bettari L, Rolfo C, Porto I, Gonzalo N, Varbella F, Cerrato E, Escaned J
10.4244/EIJ-D-20-01275
free
